Skip to content

Ultrasound Acute Chest Syndrome Sickle Cell Disease

Use of Point-of-Care Ultrasound (POCUS) for the Diagnosis of Acute Chest Syndrome in Patients With Sickle Cell Disease

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06880679
Acronym
POCUS
Enrollment
27
Registered
2025-03-18
Start date
2025-04-08
Completion date
2026-05-06
Last updated
2026-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Chest Syndrome, Sickle Cell Disease

Keywords

Sickle Cell Disease, Sickle Cell Anemia, Acute Chest Syndrome, POCUS, Ultrasound

Brief summary

Feasibility and reliability of ultrasound in the inpatient hematology setting.

Detailed description

Acute chest syndrome (ACS) is a complication of sickle cell disease where individuals have symptoms of fever, low oxygen levels or difficulty breathing in the setting of a new lung finding on chest x-ray. Chest x-ray is a useful tool to identify it but has some side effects. The investigators think ultrasound will be an equally feasible, reliable tool and minimize some of the side effects associated with chest x-ray. Ultrasound is a non-invasive was to obtain an image that does not require radiation.

Interventions

DEVICEPoint of Care Ultrasound

Point of Care Ultrasound during hospitalization

Sponsors

Indiana University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 25 Years
Healthy volunteers
No

Inclusion criteria

1. Age: 0-25 years old 2. Diagnosis: Patients with a documented diagnosis of sickle cell disease (any genotype) 3. Disposition: Hospitalized for a SCD-related complication (e.g. VOC)

Exclusion criteria

1. Patient is considered hemodynamically unstable to undergo consent and study procedures 2. Already has diagnosis of ACS prior to admission to inpatient unit 3. POCUS operator not available

Design outcomes

Primary

MeasureTime frameDescription
Participation rateUp to 5 daysPercentage of patients who are approached for study who agree to be on study
Retention rateUp to 5 daysPercentage of patients who remain on study
Duration of examUp to 5 daysTime taken to complete POCUS examination
Acceptability of POCUS by the medical team (physicians and nursing)Up to 5 daysAcceptability measured using a 5-point Likert Scale (Strongly Agree to Strongly Disagree) regarding use of POCUS in inpatient setting.

Secondary

MeasureTime frameDescription
Reliability of point of care ultrasound (POCUS) compared to standard of care (Chest X-ray)Up to 5 daysA positive screening of acute chest syndrome by POCUS is identification of either a lung consolidation or focal B-lines. POCUS findings will be compared to standard of care (Chest X-ray) findings to see if findings concur.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSeethal Jacob, MD

Indiana University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 3, 2026